← Back to Search

Behavioural Intervention

Education and Reminders for Lung Cancer Screening

N/A

Recruiting

Led By Gelareh Sadigh, MD

Research Sponsored by University of California, Irvine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 50-80 years of age

Be older than 18 years old

Must not have

Prior history of lung cancer

History of Alzheimer's disease or dementia

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 3 months after last patient completion of follow-up

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to improve lung cancer screening among Hispanic/Latinx individuals, who currently have limited access to healthcare services. The study will test a multi-level intervention that includes notifying primary care providers about patients

Who is the study for?

This trial is for Hispanic individuals aged 50-80 who are current or former smokers (quit within the last 15 years) with a history of heavy smoking. They must have an upcoming primary care appointment and be able to speak English or Spanish. It's focused on those in Orange County attending UCI Health clinics.

What is being tested?

The study tests if reminders to patients and providers, patient education, and financial navigation aid can increase lung cancer screenings using low dose CT scans compared to enhanced usual care. The goal is early detection of lung cancer in the Hispanic community.

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, there are no direct side effects from medications. However, participants may experience anxiety or stress related to screening outcomes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 50 and 80 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have had lung cancer before.

Select...

I have been diagnosed with Alzheimer's disease or dementia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 3 months after last patient completion of follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 3 months after last patient completion of follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 3 months after last patient completion of follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Patients' knowledge about lung cancer screening

Patients' perceived barriers of lung cancer screening

Patients' perceived benefits of lung cancer screening

+3 more

Other study objectives

Patients' experience with intervention

Providers experience with intervention

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Arm B: Empower LatinxExperimental Treatment5 Interventions

* PCP notifications of patients' LCS eligibility (addressing provider time constraints and barrier in identifying eligible patients); * Patients' education (addressing knowledge barriers); * Patients' referral to financial navigation resources (addressing health-related social risks) * Patients' reminder to discuss LCS during PCP visit.

Group II: Arm A: Enhanced Usual CareExperimental Treatment2 Interventions

Usual Care + Brief Educational Material

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Patient education

2011

Completed Phase 2

~9240

0 / 3Eligibility criteria met